Blb-NRF2-PON1 Cross-Talk in Abdominal Aortic Aneurysm Progression

Area of Science:

• Cardiovascular Research
• Biomarker Discovery
• Molecular Mechanisms of Disease

Background:

• Abdominal aortic aneurysm (AAA) is a growing vascular disease with potentially fatal outcomes.
• Understanding the molecular mechanisms driving AAA progression is crucial for effective management.
• The role of the NRF2 (nuclear factor erythroid 2-related factor 2) pathway and associated biomarkers in AAA is not fully elucidated.

Purpose of the Study:

• To investigate the relationship between specific biomarkers and AAA progression.
• To explore the involvement of the NRF2 pathway in the inflammatory processes of AAA.
• To identify potential indicators of aneurysm growth and rupture risk.

Main Methods:

• Analysis of 44 male AAA patients categorized by aneurysm diameter.
• Measurement of paraoxonase-1 (PON1), NRF2, heme oxygenase 1 (HO-1), bilirubin (Blb), and high-sensitivity C-reactive protein (hsCRP) using ELISA and routine laboratory tests.
• Statistical analysis including multiple linear regression and correlation within patient subgroups.

Main Results:

• Bilirubin and NRF2 were identified as significant determinants of PON1 concentration in the overall AAA cohort.
• Correlations suggested a failure of NRF2-dependent antioxidant mechanisms in favor of pro-inflammatory processes as AAA progresses.
• Heme oxygenase 1 (HO-1) and hsCRP were implicated in the inflammatory progression of aneurysms.
• Medium-sized aneurysms exhibited suppressed antioxidant activity and dominant inflammatory processes, potentially increasing rupture risk.

Conclusions:

• The NRF2 pathway's chronic activation in AAA may paradoxically contribute to reduction stress.
• Inflammatory markers like HO-1 and hsCRP are critical in AAA development and progression.
• Early identification of depressed antioxidant capacity and dominant inflammation in medium AAA could predict adverse outcomes and rupture.